This page, COVID-19 – Waiver of Requirement for Pharmacies to Collect and Submit Customer ID Information to the Prescription Monitoring Program, is offered by
News

News COVID-19 – Waiver of Requirement for Pharmacies to Collect and Submit Customer ID Information to the Prescription Monitoring Program

4/02/2020
  • Drug Control Program

                                                                        Notice

From:               Department of Public Health, Drug Control Program and

                        Prescription Monitoring Program (PMP)

To:                   Massachusetts Registered Pharmacies

Date:               April 1, 2020

Subject:           COVID-19 – Waiver of Requirement for Pharmacies to Collect and Submit Customer ID Information to the Prescription Monitoring Program

The COVID-19 public health emergency continues to produce an extraordinary demand on the Commonwealth's healthcare system. In light of greater infection control concerns at the pharmacy counter and upon prescription delivery, and in order to protect the health of the public and pharmacy staff through use of appropriate social distancing measures, it has become challenging to collect customer identification and signatures in compliance with 105 CMR 700.012(A).

Effective immediately, the Massachusetts Drug Control Program is waiving the requirement in 105 CMR 700.012(A) for pharmacies to collect and report a patient ID  and signature in association with dispensing a controlled substance or Additional Drug.

When submitting prescription data to the PMP, enter “COVID19” in place of the ID number in the AIR05 ASAP field (please refer to the PMP dispensing guide for instructions on each of the ASAP data fields).  No other changes are required. If you have questions, please contact the PMP by email at mapmp.dph@state.ma.us.

This waiver will remain in effect until the termination of the State of Emergency.

All applicable statutes, regulations and guidance not inconsistent with this document remain in effect.

COVID-19 – Waiver of Requirement for Pharmacies to Collect and Submit Customer ID Information to the Prescription Monitoring Program

Feedback